Here, we investigated whether a small molecule TFEB activator C1 (Song et al., 2016) discovered by us could be as effective as TFEB overexpression in attenuating tauopathy by using homozygous P301S Tau mice developed by Michael Goedert (Allen et al., 2002). Here, MAPT is linked to tauopathy.